General Newsroom Hero 1920x480 (4:1)
Our Work

Latham & Watkins Advises Antin on Sale of amedes

July 30, 2021
Germany team represents leading infrastructure investment firm in the transaction.

Latham & Watkins LLP advised Antin Infrastructure Partners (Antin) on the sale of their majority stake in amedes Group (amedes) to a consortium consisting of OMERS Infrastructure and Goldman Sachs Asset Management together with AXA IM Alts (acting on behalf of its clients). The sale price was not disclosed. The transaction is expected to close by the end of 2021 and is subject to regulatory approval and other customary closing conditions.

amedes is a leading integrated medical diagnostic provider in Germany, Belgium and Austria with a focus on specialty and complex tests. Amedes manages more than 75 laboratories and specialty medicine sites with 4,000+ employees (including 480+ physicians and scientists) conducting 400,000+ analyses  every day. A key differentiator is amedes integration of specialty lab diagnostics with multidisciplinary patient care capabilities, which positions amedes as a trusted partner to deliver comprehensive diagnostic and therapeutic services. Furthermore, amedes has been instrumental in the fight against the COVID-19 pandemic in Germany and Belgium, conducting not only numerous PCR tests, but also mutation screening of positive test.

Antin Infrastructure Partners is one of the world’s leading infrastructure investment firms. Based in Paris, London and New York, Antin targets majority stakes in social infrastructure, infrastructure businesses in the energy and environment, telecom and transport sectors. Since its founding, Antin has raised approximately €19 billion in commitments from its global fund investor base and has made investments in 29 companies.

The Latham team was led by Munich private equity partners Burc Hesse and Sebastian Pauls with associates Chris Freitag, Corinna Freudenmacher and Julia Schöfer. Advice was also provided on corporate/healthcare matters by Hamburg partner Christoph Engeler and associate Philipp Thomssen; on finance matters by Munich partner Thomas Weitkamp and associate Philipp Guggeis; on antitrust matters by Frankfurt partner Max Hauser, Hamburg counsel Jana Dammann de Chapto and Frankfurt associate Alisia Haber; on corporate/IP matters by Frankfurt partner Susan Kempe-Mueller; on regulatory matters by Frankfurt counsel Joachim Grittmann; on tax matters by Munich counsel Ulf Kieker; and on employment matters by Munich associate Kristina Steckermeier.